Role of the prosequence of guanylin

Protein Science

Volumn 8, Issue 9, 1999, Pages 1850-1859

  Schulz, Axel ^a   Marx, Ute C ^a,b   Hidaka, Yuji ^c   Shimonishi, Yasutsugu ^c   Rösch, Paul ^b   Forssmann, Wolf Georg ^a   Adermann, Knut ^a  

^a IPF PHARMACEUTICALS GMBH   (Germany)

^b UNIVERSITY OF BAYREUTH   (Germany)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Disulfide coupled folding; Disulfides; Folding; Guanylin; Proguanylin; Prohormone; Propeptide; Prosequ ence

Indexed keywords

AMINO ACID; CYSTEINE; GUANYLATE CYCLASE; GUANYLIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; DISULFIDE BOND; HUMAN; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN FOLDING;

EID: 0032871599     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.8.9.1850     Document Type: Article

References (52)

1. Adermann K, Neitz S, Marx UC, Rösch P, Forssmann, WG. 1996. Synthesis of human guanylin: Temperature-dependent HPLC, CZE and NMR studies verify stereoisomerism of a disulfide-containing peptide. In: Epton R, ed. Innovation and perspectives in solid phase synthesis. Birmingham, UK: Mayflower Scientific. pp 299-302.
2. Anfinsen CB. 1973. Principles that govern the folding of protein chains. Science 181:223-230.
3. Badock V, Raida M, Adermann K, Forssmann WG, Schrader M. 1998. Distinction of the three disulfide isomers of guanylin 99-115 by low-energy collision-induced dissociation. Rapid Commun Mass Spectmm 12:1952-1956.
4. Cavannagh J, Rance M. 1992. Suppression of cross-relaxation effects in TOCSY spectra via a modified DIPSI-2 mixing sequence. J Magn Reson 96:670-678.
5. Chao AC, de Sauvage FJ, Dong YJ, Wagner JA, Goeddel DV, Gardner P. 1994. Activation of intestinal CFTR chloride channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase. EMBO J 13:1065-1072.
6. Currie MG, Fok KF, Kato J, Moore RJ, Hamra FK, Duffin KL, Smith CE. 1992. Guanylin: An endogenous activator of intestinal guanylate cyclase. Proc Natl Acad Sci USA 89:947-951.
7. Deleage G, Roux B. 1987. An algorithm for protein secondary structure prediction based on class prediction. Protein Eng 1:289-294.
8. de Sauvage FJ, Keshav S, Kuang WJ, Gillett N, Henzel W, Goeddel DV. 1992. Precursor structure, expression, and tissue distribution of human guanylin. Proc Natl Acad Sci USA 89:9089-9093.
9. Ernst RR. 1992. Nuclear magnetic resonance Fourier transform spectroscopy. Angew Chem Int Ed Engl 31:805-823.
10. Fan X, Hamra FK, London RM, Eber SL, Krause WJ, Freeman RH, Smith CE, Currie MG, Forte LR. 1997. Structure and activity of uroguanylin and guanylin from the intestine and urine of rats. Am J Phys 273:E957-E964.
11. Fisher D, Eisenberg D. 1996. Protein fold recognition using sequence-derived predictions. Protein Sci 5:947-955.
12. Forte LR, Currie MG. 1995. Guanylin: A peptide regulator of epithelial transport. FASEB J 9:643-650.
13. - secretion in human intestinal T84 cells via cyclic guanosine monophosphate. J Clin Invest 91:2423-2428.
14. Garcia KC, de Sauvage FJ, Struble M, Henzel W, Reilly D, Goeddel DV. 1993. Processing and characterization of human proguanylin expressed in Escherichia coli. J Biol Chem 268:22397-22401.
15. Geourjon C, Deleage G. 1995. SOPMA: Significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci 11:681-684.
16. Giannella R. 1995. Escherichia coli heat-stable enterotoxins, guanylins and their receptors: What are they and what do they do? J Lab Clin Med 125: 173-181.
17. Gibbs SJ, Johnson CS Jr. 1991. A PFG-NMR experiment for accurate diffusion and flow studies in the presence of Eddy currents. J Magn Reson 93:395-402.
18. Gibrat JF, Garnier J, Robson B. 1987. Further developments of protein secondary structure prediction using information theory. New parameters and considerations of residue pairs. J Mol Biol 198:425-443.
19. Greenfield N, Fasman GD. 1969. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 8:4108-4116.
20. Hamra FK, Eber SL, Chin DT, Currie MG, Forte LR. 1997. Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity. Proc Natl Acad Sci USA 94:2705-2710.
21. Hamra FK, Fan X, Krause WJ, Freeman RH, Chin DT, Smith CE, Currie MG, Forte LR. 1996. Prouroguanylin and proguanylin: Purification from colon, structure, and modulation of bioactivity by proteases. Endocrinology 137:257-265.
22. Hidaka Y, Ohno M, Hemmasi B, Hill O, Forssmann WG, Shimonishi Y. 1998. In vitro disulfide-coupled folding of guanylyl cyclase activating peptide (GCAP-II) and its precursor protein (proGCAP-II). Biochemistry 37:8498-8507.
23. Hwang TL, Shaka AJ. 1995. Water suppression that works. Excitation sculpting using arbitrary wave forms and pulsed field gradients. J Magn Reson 112:275-279.
24. Jones DT, Taylor WR, Thornton JM. 1992. A new approach to protein fold recognition. Nature 358:86-89.
25. Kaever V, Resch K. 1985. Are cyclic nucleotides involved in the initiation of mitogenic activation of human lymphocytes? Biochim Biophys Acta 846:216-225.
26. Kita T, Smith CE, Duffin KL, Fok KF, Currie MG. 1995. Characterization of bioactive guanylin released from rat small intestine. FASEB J 9:A632.
27. Klodt J, Kuhn M, Marx UC, Martin S, Rösch P, Forssmann WG, Adermann K. 1997. Synthesis, biological activity and isomerism of guanylate cyclase C-activating peptides guanylin and uroguanylin. J Pept Res 50:222-230.
28. Kowit JD, Maloney J. 1982. Protein cleavage by boiling in sodium dodecyl sulfate prior to electrophoresis. Anal Biochem 123:86-93.
29. Kuhn M, Raida M, Adermann K, Schulz-Knappe P, Gerzer R, Heim JM, Forssmann WG. 1993. The circulating bioactive form of human guanylin is a high molecular weight peptide (10.3 kDa). FEBS Lett 318:205-209.
30. Kumagaye SI, Kuroda H, Nakajima K, Watanabe TX, Kimura T, Masaki T, Sakakibara S. 1988. Synthesis and disulfide structure determination of porcine endothelin: An endothelium-derived vasoconstricting peptide. Int J Pept Protein Res 32:519-526.
31. Levin JM, Gamier J. 1988. Improvements in a secondary structure prediction method based on a search for local sequence homologies and its use as a model building tool. Biochim Biophys Acta 955:283-295.
32. Ozaki H, Kubota H, Sato T, Hidaka Y, Tamaoki H, Kobayashi Y, Kyogoku Y, Sugimura T, Tai A, Shimonishi Y. 1991a. Conformation in solution of the fully toxic domain of heat-stable enterotoxin (STp) by enterotoxigenic Escherichia coli. Bull Chem Soc Jpn 64:1136-1144.
33. Ozaki H, Sato T, Kubota H, Hata Y, Katsube Y, Shimonishi Y. 1991b. Molecular struclure of the toxic domain of heat-stable enterotoxin produced by a pathogenic strain of Escherichia coli. J Biol Chem 266:5934-5941.
34. Price-Carter M, Gray WR, Goldenberg DP. 1996. Folding of ω-conotoxins. 1. Efficient disulfide-coupled folding of mature sequences in vitro. Biochemistry 35:15537-15546.
35. Rittenhouse J, Marcus F. 1984. Peptide mapping by polyacrylamide gel electrophoresis after cleavage at aspartyl-prolyl peptide bonds in sodium dodecyl sulfate-containing buffers. Anal Biochem 138:442-448.
36. Rost B, Sander C. 1993. Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol 232:584-599.
37. Rost B, Sander C. 1994. Combining evolutionary information and neural networks to predict protein secondary structure. Proteins 19:55-72.
38. Rost B, Schneider R, Sander C. 1997. Protein fold recognition by prediction-based threading. J Mol Biol 270:471-480.
39. Schmid FX. 1989. Optical spectroscopy to characterize protein conformation. In: Creighton TE, ed. Protein structure: A practical approach. Oxford, UK: IRL Press, pp 251-285.
40. Schrader M, Jürgens M, Hess R, Schulz-Knappe P, Raida M, Forssmann WG. 1997. Matrix-assisted laser desorption/ionisation mass spectrometry guided purification of human guanylin from blood ultrafiltrate. J Chromatogr A 776:139-145.
41. Schulz S, Chrisman TD, Garbers DL. 1992. Cloning and expression of guanylin. J Biol Chem 267:16019-16021.
42. Schulz A, Escher S, Marx UC, Meyer M, Rösch P, Forssmann WG, Adermann K. 1998. Carboxy-terminal extension stabilizes the topological stereoisomers of guanylin. J Pept Res 52:518-525.
43. Schulz S, Lopez MJ, Kuhn M, Garbers DL. 1997. Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice. J Clin Invest 100:1590-1595.
44. Shinde U, Inouye M. 1993. Intramolecular chaperones and protein folding. Trends Biochem Sci 18:442-446.
45. Skelton NJ, Garcia KC, Goeddel DV, Quan C, Burnier JP. 1994. Determination of the solution structure of the peptide hormone guanylin: Observation of a novel form of topological stereoisomerism. Biochemistry 33:13581-13592.
46. Sreerama N, Woody RW. 1993. A self-consistent method for the analysis of protein secondary structure from circular dichroism. Anal Biochem 209: 32-44.
47. Vandraager AB, Bot AG, de Jonge HR. 1997. Guanosine 3′,5′-cyclic monophosphate-dependent protein kinase II mediates heat-stable enterotoxin-provoked chloride secretion in rat intestine. Gastroenterology 112:437-443.
48. van Zijl PCM, O'Neil Johnson M, Mori S, Hurd RE. 1995. Magic-angle-gradient double-quantum-filtered COSY. J Magn Reson 113:265-270.
49. 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest neighbor effects. J Biomol NMR 5:67-81.
50. Wishart DS, Sykes BD, Richards FM. 1991. Relationship between nuclear magnetic resonance chemical shifts and protein secondary structure. J Mol Biol 222:311-333.
51. Wüthrich K. 1986. NMR of proteins and nucleic acids. New York: John Wiley & Sons.
52. Yamaguchi H, Nakazato M, Miyazato M, Kangawa K, Matsuo H, Matsukura S. 1995. Two novel rat guanylin molecules, guanylin-94 and guanylin-16, do not increase cyclic GMP production in T84 cells. Biochem Biophys Res Commun 214:1204-1210.